Drägerwerk AG & Co. KGaA

DRW3

DE0005550636

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate Other stock markets 09:20:57 2024-07-17 EDT			5-day change	1st Jan Change
51 ^EUR	-1.73%		-5.75%	-1.93%

07-16	DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating	ZD
07-15	Metzler rates Drägerwerk at 'Hold' - Target 50 euros	DP

DRAEGERWERK : Independant Research reiterates its Sell rating

January 21, 2020 at 06:54 am

Independant Research's analyst Tobias Gottschalt maintains his Sell rating on the stock. The target price is lowered from EUR 52 to EUR 50.

Latest news about Drägerwerk AG & Co. KGaA

DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating	07-16	ZD
Metzler rates Drägerwerk at 'Hold' - Target 50 euros	07-15	DP
Drägerwerk's profit rises - shares up slightly	07-15	DP
DRAEGERWERK : Warburg Research remains its Buy rating	07-15	ZD
DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating	07-09	ZD
DRAEGERWERK : Jefferies maintains a Sell rating	07-02	ZD
Warburg Research raises target for Drägerwerk to 64 euros - 'Buy'	06-20	DP
DRAEGERWERK : Warburg Research gives a Buy rating	06-20	ZD
Ailing hospitals slow down German medical technology sector	05-23	DP
DRÄGERWERK AG & CO KGAA : China weighs on Q1 24 growth	05-01
DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating	04-29	ZD
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15	04-25	DP
Transcript : Drägerwerk AG & Co. KGaA, Q1 2024 Earnings Call, Apr 25, 2024	04-25
Drägerwerk AG & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Drägerwerk AG & Co. KGaA Provides Earnings Guidance for the Year 2024	04-25	CI
DRÄGERWERK AG & CO KGAA : Silver lining beyond the soft Q124 headline figures	04-16
DRAEGERWERK : Hauck & Aufhauser remains its Buy rating	04-16	ZD
: Drägerwerk starts the year with lower sales - outlook confirmed	04-16	DP
Jefferies rates Drägerwerk at 'Underperform' - Target 42 euros	04-16	DP
DRAEGERWERK : Jefferies gives a Sell rating	04-16	ZD
Roundup: Drägerwerk starts the year with lower sales - outlook confirmed	04-15	DP
Drägerwerk starts the new year with a slight decline in sales	04-15	DP
DRÄGERWERK AG & CO KGAA : EPS upgrade (2023: +14.2%, 2024: +3.8%)	04-15
DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating	03-22	ZD
DRÄGERWERK AG & CO KGAA : FY23: Dividend surprise holds centre-stage	03-08

Chart Drägerwerk AG & Co. KGaA

Duration

Period

More charts

Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The Company operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The Company has production sites in Europe, the Americas, Africa and Asia.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-25 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DRÄGERWERK AG & CO KGAA : China weighs on Q1 24 growth

May 01, 2024 at 12:40 pm

More Strategies

Ratings for Drägerwerk AG & Co. KGaA

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

51.9 EUR

Average target price

58 EUR

Spread / Average Target

+11.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
DRÄGERWERK AG & CO. KGAA	-1.93%	994M
THERMO FISHER SCIENTIFIC	+4.64%	212B
DANAHER CORPORATION	+8.99%	187B
INTUITIVE SURGICAL, INC.	+29.83%	155B
BOSTON SCIENTIFIC CORPORATION	+35.17%	115B
SIEMENS HEALTHINEERS AG	+1.60%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+15.06%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	45.25B
AGILENT TECHNOLOGIES, INC.	-2.14%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	37.72B

Other Advanced Medical Equipment & Technology

Drägerwerk AG & Co. KGaA

Equities

DRW3

DE0005550636

Advanced Medical Equipment & Technology

DRAEGERWERK : Independant Research reiterates its Sell rating

Latest news about Drägerwerk AG & Co. KGaA

Chart Drägerwerk AG & Co. KGaA

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Drägerwerk AG & Co. KGaA

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology